Engflag

Doxyval 20%

Quick links to important sections

Doxyval 20%

There is no image.

Method of action: Antibacterial Broad Spectrum (Bactericidal), Bacteriostatic

Treatment option: Abscess, Lung Abscess, Actinomycosis, Bartonellosis, Lyme Disease, Bronchitis, Bronchopneumonia, Brucellosis, Bubonic Plague, Lymphogranuloma Venereum

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Doxyval 20%

Property Description
Active ingredient Doxycycline (usually as Doxycycline hyclate)
Form Soluble powder (Oral powder)
Pharmacological class Tetracycline-class Antibiotic
Common use Anti-infective agent for bacterial pathogens
Origin Semi-synthetic

Doxyval 20% is a specific pharmaceutical preparation containing the semi-synthetic antibiotic Doxycycline, which is formally classified as a Tetracycline-class Drug. This agent's active component is derived from the natural tetracycline Oxytetracycline through chemical modification, a process designed to provide improved stability and absorption compared to first-generation compounds. The product's identity is further defined by its specific target audience and delivery method, being primarily positioned for veterinary use.

Composition and Pharmaceutical Form

The medicine is a single active ingredient product centered on Doxycycline, typically delivered as the hyclate salt, and is standardized at a high 20% concentration. Doxyval 20% is uniquely presented as a soluble powder intended for oral administration after reconstitution, often into drinking water or feed. This powder form is utilized for large-volume administration to provide a consistent dose across a target group. Tetracyclines are used in treating a variety of infections due to their broad spectrum of activity.

Mechanism: How Does Doxycycline Function?

Doxycycline primarily functions as a bacteriostatic agent by halting the growth of susceptible bacterial populations. The mechanism involves the drug binding reversibly to the 30S ribosomal subunit within the bacterial cell. This action prevents the bacteria from carrying out the process of protein synthesis, which is necessary for their proliferation and survival. This established mechanism of action is intended to halt the progression of infection at the cellular level.

Regulatory References

  1. National Library of Medicine

What side effects are possible with Doxyval 20%?

Possible side effects and safety information

The safety profile of Doxycycline, the active ingredient in Doxyval 20%, is defined by its official classification of adverse reactions and specific regulatory constraints, strictly based on government-approved labeling.

Officially Documented Adverse Reactions

Adverse reactions are formally grouped by the affected System-Organ-Class (SOC) and categorized by their frequency of occurrence as listed in official prescribing information.

  • Common Reactions (Gastrointestinal Disorders): These typically involve the digestive system and are the most frequently observed effects, including nausea and vomiting.
  • Rare or Uncommon Reactions (SOCs): These include serious effects classified under Skin and Subcutaneous Tissue Disorders (e.g., photosensitivity, severe rashes) and Nervous System Disorders (e.g., benign intracranial hypertension).

Serious Safety Considerations

The regulatory profile identifies clinically significant adverse reactions, though they are generally considered rare:

  • Severe Cutaneous Adverse Reactions (SCARs): Specific severe skin conditions, such as Stevens-Johnson Syndrome (SJS), are officially documented concerns.
  • Hypersensitivity: Severe, immediate reactions are a documented possibility.
  • Pseudomembranous Colitis: A severe form of antibiotic-associated colitis is listed in official safety documents.

Population and Duration Constraints

Official labels mandate specific constraints related to patient demographics and duration of exposure:

  • Developing Teeth: The medication is officially restricted in individuals during the period of tooth development (generally children under 8 years of age) due to the risk of permanent tooth discoloration.
  • Time-Related Patterns: Gastrointestinal effects are often more frequently observed at the start of therapy. Additionally, photosensitivity reactions may manifest shortly after treatment initiation.
  • Contraindication: A known hypersensitivity to Doxycycline or any other tetracycline antibiotic serves as an absolute restriction on its use.

Overdose and Emergency Response

Overdose involving Doxyval 20% is officially documented as typically resulting in an exaggeration of known adverse effects, including severe nausea, vomiting, and diarrhea. However, regulators classify certain severe outcomes associated with elevated exposure as life-threatening. These include the risk of Intracranial Hypertension (IH), which may manifest as headache, blurred vision, or double vision and can carry the potential for permanent visual loss. Additionally, severe gastrointestinal complications, such as Fatal Colitis (Clostridium difficile-associated diarrhea), have been reported in the context of antibacterial use. Overweight women of childbearing age are noted in labeling as a population at potentially higher risk for developing IH.

In the event of a known or suspected overdose, immediate medical attention must be sought. Urgent help is required if the affected individual exhibits severe signs such as collapse, seizure, trouble breathing, or unresponsiveness. Furthermore, prompt ophthalmologic evaluation is specifically warranted if any visual disturbance occurs during high exposure. The official management profile confirms that treatment is symptomatic and supportive. No specific antidote is known, and regulatory sources state that procedures like dialysis are ineffective in removing the drug.

Therapeutic Uses of Doxyval 20%

What Doxyval 20% Treats: Main Uses and Benefits

Doxyval 20% (Doxycycline) is a tetracycline-class anti-infective agent applied across various fields to address active bacterial diseases and is used to help ease symptoms. This compound is commonly used in cattle, pigs, dogs, and cats for the treatment of infections due to susceptible bacteria, and its use is consistent with the established therapeutic domain of the tetracycline class.

The medication is commonly used to manage infections presenting with symptoms related to systemic imbalance, such as high fever and lethargy. Its therapeutic applications include managing conditions related to vector-borne pathogens (like those causing Ehrlichiosis), applied in addressing respiratory infections characterized by coughing and nasal discharge, and supporting health in conditions associated with chronic inflammation, such as periodontal disease.

“It is often used during phases when symptoms become more noticeable, providing support that helps ease the overall symptom burden.”

In its role, the medication contributes to easing the symptomatic distress and assists with managing symptom clusters that may become intense or disruptive.

Quick Fact: Support for Respiratory Symptoms
This medication is relevant for easing symptoms that interfere with daily functioning, supporting general well-being during periods of respiratory functional stress.

Regulatory References

  1. European Medicines Agency

Eligibility and Restrictions for Use

Doxyval 20% (doxycycline) is a tetracycline-class antibiotic primarily used to treat various bacterial infections, as well as for certain anti-inflammatory conditions like rosacea.

Who Can Use Doxyval 20%?

  • Adults and most children aged 8 years and older can use this medication.
  • Its use is generally indicated for susceptible bacterial infections, including some respiratory and urinary tract infections, severe acne, and certain sexually transmitted infections.

Who Should Not Use Doxyval 20%?

Contraindication Category Exclusion Criteria
Allergies Individuals with a known hypersensitivity or allergic reaction to doxycycline or any other tetracycline antibiotics.
Pediatric Children under 8 years of age should generally avoid this drug due to the risk of permanent tooth discoloration and effects on bone development, unless treating a severe or life-threatening condition (e.g., anthrax or Rocky Mountain spotted fever) where the benefit outweighs the risk.
Pregnancy/Breastfeeding Pregnant women (especially during the second and third trimesters) and breastfeeding mothers are typically advised against use, as doxycycline can affect tooth and bone development in the fetus or infant.
Drug Interactions Patients taking isotretinoin, acitretin, or other oral retinoids due to an increased risk of elevated pressure around the brain (intracranial hypertension).

What should I know about interactions with other medicines?

Interactions with other medicines and products

Doxyval 20% (Doxycycline) may interact with several other medicinal products and substances. These interactions are categorized based on their clinical significance as documented in official regulatory labeling.

Contraindicated Combinations

Combination with systemic Retinoids (e.g., Isotretinoin) must be avoided due to the documented risk of increased intracranial pressure. Co-administration with Penicillins should also be avoided, as Doxycycline's bacteriostatic action may interfere with the bactericidal effect of penicillins.

Clinically Significant Interactions

Interacting Product Category Effect / Management Guideline
Anticoagulants (e.g., Warfarin) Doxycycline may depress plasma prothrombin activity, increasing the anticoagulant effect. Dosage adjustment and monitoring are required.
Cation-Containing Products Antacids, iron supplements, and other products containing multivalent cations (calcium, aluminum, magnesium) impair Doxycycline absorption. A time separation of 1–2 hours between doses is necessary.
Enzyme Inducers Drugs like Phenytoin, Phenobarbital, and Carbamazepine accelerate Doxycycline metabolism, leading to a reduced serum half-life.
General Anesthetics Caution is advised with Methoxyflurane due to the documented risk of severe renal toxicity associated with the tetracycline class.

Chronic heavy alcohol use is also noted to reduce the Doxycycline half-life. Users of oral contraceptives should be advised that the effectiveness of the contraceptive may be diminished.

Mechanism of Action

The mechanism of Doxyval 20% (Doxycycline) operates across two primary domains: highly targeted bacterial growth inhibition and the modulation of host inflammatory processes.

Protein Synthesis Inhibition via Ribosomal Blockade

The drug acts as an inhibitor by binding reversibly to the bacterial 30S ribosomal subunit. This interaction causes steric obstruction, blocking the A-site where aminoacyl-tRNA typically docks. The resulting mechanistic cascade is the stalling of the polypeptide chain elongation phase, which culminates in the cessation of bacterial proliferation (a bacteriostatic effect).

Modulation of Host Inflammation and Mechanistic Constraints

Beyond the antimicrobial action, the mechanism involves modulating host pathways by inhibiting enzymes such as Nitric Oxide Synthase and interfering with leukocyte chemotaxis. This action reduces the output of inflammatory mediators, contributing to the modulation of the host's physiological inflammatory reaction.

Efficacy is constrained by bacterial counter-mechanisms, particularly plasmid-encoded efflux pumps. These specialized transporter proteins actively expel the drug from the bacterial cytoplasm, lowering the intracellular concentration and preventing the core inhibitory mechanism from operating effectively.

Dosage and Administration Information

How to Use Doxyval 20% (Doxycycline Oral Suspension)

This section describes the administration of Doxyval 20% oral suspension for the active ingredient, doxycycline.

Administration Guidelines

Doxyval 20% is prescribed for oral administration and must be taken once daily.

Administration Detail Requirement
Dosing Schedule 20 mg of doxycycline once daily.
Timing in Relation to Meals Take the dose at least one hour before or two hours after a meal.
Preparation Shake the oral suspension well immediately before use to ensure proper mixing. Measure the dose using the calibrated dosing device provided.
Age Group Approved for use in adults and pediatric patients 8 years of age and older.
Missed Dose If a dose is missed, resume the schedule with the next scheduled dose. Do not take two doses at the same time to make up for a missed dose.

Procedural Steps

To ensure proper dosing and absorption, the following sequence of steps is followed:

  1. Shake the Doxyval 20% oral suspension vigorously before each administration.
  2. Measure the required dose (20 mg) using the calibrated dosing device provided with the product.
  3. Swallow the measured volume of the suspension.
  4. Ensure the dose is administered on an empty stomach, respecting the one-hour-before/two-hours-after meal restriction.
  5. Repeat this procedure once every 24 hours.

Recent Clinical Evidence

Evidence for Use in Vector-Borne Pathogen Diseases

Research has been studied for its use in dogs with naturally acquired or experimentally induced vector-borne infections, such as those caused by Ehrlichia canis. The evidence base includes systematic reviews and meta-analyses that synthesized findings from multiple controlled and non-randomized trials. Research primarily monitored hematological parameters, like platelet and red blood cell counts, and examined measurements of pathogen load (the amount of bacteria present) during defined time intervals. Findings describe patterns observed in the studies regarding measured shifts in blood markers. However, reported outcomes varied across studies, and certainty remains low due to research reliance on surrogate endpoints (biomarkers) over long-term clinical outcomes.

Evidence for Use in Respiratory Tract Infections

Doxycycline was studied for its role in relation to research exploring bacterial infections of the respiratory tract. The research structure includes randomized, controlled clinical trials in populations like kittens and cats presenting with episodic or acute changes. These trials examined outcomes related to physical discomfort, specifically using clinical symptom scores. Studies reported that in some instances, the observed clinical changes did not align perfectly with the measurements of pathogen load. Existing studies provide limited insight into this area. Follow-up durations were limited, and the results apply only to the populations studied.

Evidence in Production Groups and Research Gaps

Evidence also includes systematic reviews and meta-analyses of field and controlled trials exploring outcomes for large animal groups like broiler chickens. The research examined endpoints like mortality rates (survival) and production metrics. The evidence quality varies across these studies, as many trials were noted to have Risk of Bias (RoB) concerns, meaning the overall certainty of the synthesized data remains low in some aspects. Furthermore, long-term effects are not fully established for most uses, and comparative evidence is lacking for certain indications. Data for certain specific groups remain insufficient, and the research landscape notes a need for more high-quality randomized controlled trials across several key areas.

Key Studies & References

  1. Hematologic recovery in Ehrlichia-infected dogs: A meta-analysis of doxycycline's therapeutic impact

How should Doxyval 20% be stored and disposed of?

The official regulatory requirements for Doxyval 20% Soluble Powder (Veterinary) define the conditions necessary for its stability and safe handling.

️ Storage and Stability

The product should be stored in the original container, in a dry place, and must be kept out of the sight and reach of children. While the powder requires no special storage conditions, it must be protected from frost and should not be refrigerated or frozen. The shelf-life after first opening the container is typically 12 months. After the powder is diluted in drinking water, the medicated solution is stable for 24 hours and must be discarded after this period.

️ Disposal Instructions

Any unused veterinary medicinal product or waste material must be disposed of in accordance with local requirements for pharmaceutical waste. The product must not be allowed to enter wastewater or the environment, as Doxycycline is documented as being toxic to aquatic life.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagFrance

Equivalent of Doxyval 20% found in:

A-Z Index: